Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
CRD-TMH-001The study is a single patient study intended to understand the effects of a gene-editing therapeutic to treat a rare mutation of Duchenne muscular dystrophy. Myopathies Phase 1 À vérifier United States À vérifier
CRD-TMH-001The study is a single patient study intended to understand the effects of a gene-editing therapeutic to treat a rare mutation of Duchenne muscular dystrophy. Myopathies Phase 1 À vérifier United States À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
CRD-TMH-001 Myopathies Phase 1 NCT05514249 Treatment of a Single Patient With CRD-TMH-001 COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.